Single infusion of zoledronate in Paget's disease of bone: a placebo-controlled, dose-ranging study.
D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D015415:Biomarkers / Q000097:blood / Q000652:urine; D001862:Bone Resorption / Q000188:drug therapy / Q000517:prevention & control; D003404:Creatinine / Q000652:urine; D004164:Diphosphonates / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D006909:Hydroxyproline / Q000652:urine; D007093:Imidazoles / Q000008:administration & dosage* / Q000009:adverse effects; D007262:Infusions, Intravenous; D008297:Male; D010001:Osteitis Deformans / Q000188:drug therapy* / Q000201:enzymology; D000077211:Zoledronic Acid